Drug Delivery News: Breaking Drug Delivery News, Comments and Articles. - Page: 5

Heptares Augments Business Development Capabilities in Japan and Other Asian Territories

WELWYN GARDEN CITY, England and BOSTON, May 24, 2013 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR drug discovery and development company, is pleased to announce that it has engaged Mr Akira Usui as a Consultant to augment the Company's business development capabilities in Japan and other Asian territories. Mr Usui has more than 15 years of experience in business development, licensing...

J&J investor day: A club drug for depression and an Alzheimer's pledge

Johnson & Johnson sees great potential in a club drug to treat depression, isn’t giving up on treating Alzheimer’s disease and is investing heavily in immunotherapy for cancer. Those tidbits come courtesy of.....

Actavis To Increase Operational Synergies By Acquiring Warner

ByAlpha Hunter:The pharmaceutical industry is one of the biggest industries in the world. Currently the global pharmaceutical industry is worth $300 billion a year, and expected to reach $400 billion in the coming few years. According to the World Health Organization, the top 10 drug makers control around one-third of the global pharmaceutical market. Six of them are based in the United States and...

Drug addiction can be visualized in specific regions of the brain that determine decision-making

New research shows that craving drugs such as nicotine can be visualized in specific regions of the brain that are implicated in determining the value of actions, in planning actions and in motivation.

[Clinical Picture] Bullosis diabeticorum

A 60-year-old man with history of uncontrolled diabetes mellitus was admitted for investigation of back pain. 2 days after his admission, an overnight spontaneous eruption of a 9×4 cm, tense, non-tender bullous lesion on the dorsum of his right foot...

Glaxo Alleges Errors In Nissen’s Critique Of FDA’s Handling Of Avandia

This morning, I published a guest post from Steven Nissen, Chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic, alleging that the most likely rationale for an upcoming panel meeting being held by the Food and Drug Administra...

Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds

FRIDAY, May 24 (HealthDay News) -- Drugs commonly used to treat glaucoma may cause droopy eyelids and other side effects that can interfere with vision, according to a new study. The drugs, known as prostaglandin analogues (PGAs), which are used to...

World Lung Foundation Warns U.S. Budget Cuts Will Slow The Fight Against Multi-Drug Resistant Tuberculosis

World Lung Foundation (WLF) today warned that the sequestration of the United States Federal Budget will have the unintended consequence of slowing efforts to control and eradicate tuberculosis - particularly multi-drug resistant tuberculosis - both...

Guangdong May Group Drugs Into Five Types For Separate Price Review

Guangdong has released its pharma procurement draft rules for consultation, stating it would use a third-party online platform to request EDL drug tenders for all public hospitals.

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

First Manhattan Still Playing Hardball With Vivus

By Spencer Osborne: First Manhattan, an investor with about a 10% stake in Vivus (VVUS), has now taken the step of increasing its slate of Board nominations with the addition of a 9th nominee. Essentially, expressing disappointment in the current management and Board of Directors, First Manhattan is seeking to gain control of Vivus through a cherry picked Board of Directors.The sparring match betw...

Bioresorbable Drug-Eluting Scaffolds Emerging As The Dominant Device Of The Future For Percutaneous Coronary Interventions

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013. DES...

New Pneumococcal Vaccine Appears To Be As Safe As Previously Used Vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published in Vaccine. The U.S. Food...

Treatment For Cocaine Addiction In Animal Model

Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe for humans, is undergoing...

AAPS PharmSciTech: Agglomerated Oral Dosage Forms of Artemisinin/β-Cyclodextrin Spray-Dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability

Type: Original PaperArtemisinin, a poorly water-soluble antimalarial drug, presents a low and erratic bioavailability upon oral administration. The aim of this work was to study an agglomerated powder dosage form for oral administration of artemisini...

Pharmaceutical Research: Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease

Type: Original PaperPurposeTo prepare an angiopep-conjugated dendrigraft poly-L-lysine (DGL)-based gene delivery system and evaluate the neuroprotective effects in the rotenone-induced chronic model of Parkinson’s disease (PD).MethodsAngiopep was a...

Pharmaceutical Research: In Vitro Assessment of NSAIDs-Membrane Interactions: Significance for Pharmacological Actions

Type: Original PaperPurposeTo study interactions between nonsteroidal anti-inflammatory drugs (NSAIDs) and membrane mimetic models.MethodsThe interactions of indomethacin and nimesulide with liposomes of dipalmitoylphosphatidylcholine (DPPC) at two p...

Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution

A pioneer and leading provider of population health and business intelligence solutions, i2i Systems announced in a press release that the 2011 Malcolm Baldrige National Quality Award-winning Southcentral Foundation (SCF) selected i2iTracks as their population management solution. SCF will utilize i2iTracks to help them meet their Meaningful Use, Government Performance and Results Act, and Uniform...

Novel saltwater treatment device for cystic fibrosis

May 22, 2013 - Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in a revolutionary new aerosol delivery system. It enables CF sufferer...

Sequestration Funding Cuts Jeopardize TB Clinical Drug Trials

ATS 2013, PHILADELPHIA - Innovative and potentially game-changing clinical trials to develop new drug regimens to prevent and treat tuberculosis (TB), the second leading global infectious disease killer, are in jeopardy due to federal "sequestration" funding cuts. New CDC-funded TB treatment study findings were announced today in Philadelphia at the American Thoracic Society annual meeting where,...

Healthtech Assists Clients With Sector-Wide Challenges

TORONTO, ONTARIO -- (Marketwired) -- 05/24/13 -- Editors' Note: There is a photo associate with this release. Every healthcare organization is unique, but many challenges are shared. In response to these sector-wide challenges we've developed an integrated set of solutions, tailored to meet specific organizational requirements in several key business areas. Each solution is standalone and compri...

Drug-Resistant TB Destroyed By Vitamin C

In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C ad...

Results Of The BIOFLOW-II Substudy: Biodegradable Stent Proves Non-Inferior To Drug-Eluting Stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent late lumen loss at nine mont...

1-Year TAVI Outcomes Post-Approval Showed A Large Treatment Effect In Terms Of Symptom Relief And Improved Quality Of Life

One-year results from SOURCE XT - one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date - reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, with high rates of device...

Study Clarifies Roles Of Anti-Angiogenic Proteins In Discouraging Metastasis And Reveals Potential Anti-Metastasis Drug

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse...